MED-EL hearing solution registry: An examination of the strengths and limitations of a cochlear implant registry.

ABSTRACT: There is a significant gap in routine clinical data concerning cochlear implant (CI) users, particularly regarding real-world outcomes. To address this, the present study focuses on the MED-EL Hearing Solution (MEHS) multicenter registry, which covers 5 clinics in Germany. Participants were users of a SONNET 2 or SONNET 2 EAS audio processor. Anonymized data that were routinely collected were extracted and analyzed by a third-party organization. Speech test outcomes (monosyllables and numbers), hours of daily use, self-perceived level of auditory benefit, and safety were assessed. Outcomes from 361 SONNET 2 (or SONNET 2 EAS) users, including 57 bilateral users, were extracted and analyzed. Speech test outcomes increased significantly from pre-operatively to 1 year of CI use in monosyllable

SUBMITTER: Baumann U 

PROVIDER: S-EPMC12558452 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature